Articles Tập 67 Số CĐ9-Hội Y học Giới tính 29/07/2026

EVALUATION OF OUTCOMES OF TRANSURETHRAL SEMINAL VESICULOSCOPY IN TREATMENT OF PERSISTENT HEMATOSPERMIA AT THE CENTER OF ANDROLOGY, VIET DUC UNIVERSITY HOSPITAL IN 2025

Luu Quang Long1,2,3,4, Nguyen Lan Anh1,3, Tran Diep Quynh1,3, Nguyen Hoang Vi Thao1,3, Le Cong Minh1,3, Nguyen Huu Thao1,3, Nguyen Quang1,2,3,4
1 VNU University of Medicine and Pharmacy
2 Viet Duc University Hospital
3 Trường Đại học Y Dược, Đại học Quốc gia Hà Nội
4 Bệnh viện Hữu nghị Việt Đức
DOI: 10.52163/yhc.v67iCD9.5809
39 Views
0 Downloads
Abstract

Objectives: To describe clinical features, determine the proportion of etiologies causing persistent hematospermia diagnosed by transurethral seminal vesiculoscopy, evaluate treatment outcomes, and report complications.

Subjects and methods: Retrospective analysis of 13 male patients with persistent hematospermia (≥ 3 months) who underwent transurethral seminal vesiculoscopy at the Center of Andrology, Viet Duc University Hospital in 2025.

Results: Median age was 34 (18-53) years. The leading pre-operative diagnoses were seminal vesiculitis/vasitis (46.2%), seminal vesicle/ejaculatory duct stones (30.8%), and varicose periprostatic veins (15.4%). Endoscopy helped clarify the etiology in cases without a definite pre-operative diagnosis. All patients received definitive intervention in the same session (stone fragmentation, irrigation, vein fulguration). Median operative time was 45 minutes, and median hospital stay was 5 days (range 3-9). No intraoperative or postoperative complications were recorded; 100% of patients had complete resolution of hematospermia.

Conclusions: Transurethral seminal vesiculoscopy is a safe and effective method that allows accurate diagnosis and definitive treatment of persistent hematospermia in a single procedure.

References
[1]
Madhushankha M, Jayarajah U, Abeygunasekera A.M. Clinical characteristics, etiology, management and outcome of hematospermia: a systematic review. Am. J. Clin. Exp. Urol., 2021, 9 (1): 1-17. Google Scholar
[2]
Chen W.K et al. Transurethral seminal vesiculoscopy for intractable hematospermia: experience from 144 patients. BMC Urol., 2021, 21 (1): 48. doi: 10.1186/s12894-021-00817-4. Google Scholar
[3]
Drury R.H et al. Hematospermia etiology, diagnosis, treatment, and sexual ramifications: a narrative review. Sex. Med. Rev., 2022, 10 (4): 669-680. doi: 10.1016/j.sxmr.2021.07.004. Google Scholar
[4]
Dittmar F et al. Comprehensive evaluation of hematospermia in patients with acute epididymitis compared to patients with isolated hematospermia. Andrology, 2024, 12 (5): 1001-1011. doi: 10.1111/andr.13489. Google Scholar
[5]
Chen R et al. Transurethral seminal vesiculoscopy for recurrent hemospermia: experience from 419 cases. Asian J. Androl., 2018, 20 (5): 3. doi: 10.4103/aja.aja_76_17. Google Scholar
[6]
Abdel-Al I et al. Long-term success durability of transurethral resection of ejaculatory duct in treating infertile men with ejaculatory duct obstruction. J. Endourol., 2022, 36 (7): 982-988. doi: 10.1089/end.2021.0840. Google Scholar
[7]
Song L et al. Successful treatment of seminal vesicle calculi and prostatic utricle calculi by transurethral seminal vesiculoscopy. Andrologia, 2020, 52 (11): e13804. doi: 10.1111/and.13804 Google Scholar
[8]
Zarli M.H et al. Transurethral treatment of a seminal vesicle cyst with lithiasis: case report. Case Rep. Surg., 2025: 5599829. doi: 10.1155/cris/5599829. Google Scholar
[9]
Zheng L et al. Azoospermia due to functional and partial ejaculatory duct obstruction: a rare case report and literature review. Andrology, 2024, 18 (5): 15579883241281668. doi: 10.1177/15579883241281668 Google Scholar
[10]
Al-Harbi A. Transurethral resection of ejaculatory ducts (TURED) for the management of ejaculatory duct obstruction: a Saudi cohort. J. Mens Health, 2023, 19 (9): 76-81. doi: 10.22514/jomh.2023.086 Google Scholar